Wendy Béguelin - Concepedia

Author

Wendy Béguelin

Also Known As

Beguelin, Wendy, Béguelin, Wendy, W Beguelin, W Béguelin, W Béguelin, W. Beguelin, W. Béguelin, Wendy Beguelin, Wendy Béguelin, Wendy Béguelin

137

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Cornell University Memorial Sloan Kettering Cancer Center Consejo Nacional de Investigaciones Científicas y Técnicas Experimental Medicine and Biology Institute Weill Cornell Medicine

About

Wendy Béguelin is an author at Cornell University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	23	3.2K
2	Cell Biology	21	21	2.6K
3	Engineering	1	1	67
4	Natural Sciences	1	1	84
5	Biomedical Engineering	1	1	67

Wendy Béguelin

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation Wendy Béguelin, Relja Popovic, Matt Teater, Cancer Cell ChromatinDevelopmental BiologyGerm CellSomatic VariantGerminal Center Formation	2013	828
Loss of BAP1 function leads to EZH2-dependent transformation Lindsay M. LaFave, Wendy Béguelin, Richard P. Koche, Nature Medicine ChromatinSignal TransductionSignal RecognitionMolecular BiologyMedicine	2015	392
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition Daisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, Cancer Discovery	2019	301
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture Nevin Yusufova, Andreas Kloetgen, Matt Teater, Nature Histone ModificationsChromatinTumor BiologyLymphoid NeoplasiaChromatin Remodeling	2020	257
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis Wendy Béguelin, Matt Teater, Micah D. Gearhart, Cancer Cell Transcriptional RegulationDevelopmental BiologySignaling PathwayCell RegulationRepress Bivalent Promoters	2016	239
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop Wendy Béguelin, Martín A. Rivas, María Teresa Calvo, Nature Communications	2017	182
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma Mariano Cárdenas, Wenbo Yu, Wendy Béguelin, Journal of Clinical Investigation ImmunologyBcl6 InhibitorsImmunotherapyTumor BiologyB Cell	2016	172
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis Pilar M. Domínguez, Hussein Ghamlouch, Wojciech Rosikiewicz, Cancer Discovery	2018	159
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways Martín A. Rivas, Romina P. Carnevale, Cecilia J. Proietti, Experimental Cell Research Nf-κb-dependent PathwaysCancer ResearchBreast OncologyP42/p44 MapkSignaling Pathway	2007	157
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response Wendy Béguelin, Matt Teater, Cem Meydan, Cancer Cell Tumor BiologyLymphoid NeoplasiaMedicineImmunologyTumor Immunity	2020	146

Page 1